Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
OTLK Outlook Therapeutics
- 1.550
- -0.020-1.27%
Close May 2 16:00 ET
- 1.520
- -0.030-1.94%
Post 20:01 ET
50.56MMarket Cap-0.63P/E (TTM)
1.620High1.520Low229.10KVolume1.610Open1.570Pre Close359.45KTurnover1.11%Turnover RatioLossP/E (Static)32.62MShares9.25052wk High-1.01P/B32.15MFloat Cap0.87052wk Low--Dividend TTM20.74MShs Float219.200Historical High--Div YieldTTM6.37%Amplitude0.870Historical Low1.568Avg Price1Lot Size
About Outlook Therapeutics Company
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.
Company Profile
SymbolOTLK
Company NameOutlook Therapeutics
Listing DateJun 13, 2016
Founded2010
CEOMr. Lawrence A. Kenyon
MarketNASDAQ
Employees23
Fiscal Year Ends09-30
Address111 South Wood Avenue,Unit 100
CityIselin
ProvinceNew Jersey
CountryUnited States of America
Zip Code08830
Phone1-609-619-3990
Company Executives
- Name
- Position
- Salary
- Lawrence A. Kenyon
- Interim Chief Executive Officer, Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Principal Accounting Officer and Director
- 634.60K
- Jeff Evanson
- Chief Commercial Officer
- 768.03K
- Faisal G. Sukhtian
- Chairman of the Board
- 113.00K
- Yezan Munther Haddadin
- Independent Director
- 110.00K
- Ralph H. Thurman
- Lead Independent Director
- 242.50K
- Kurt J. Hilzinger
- Independent Director
- 95.00K
- Julian S. Gangolli
- Independent Director
- 112.50K
- Andong Huang
- Independent Director
- 75.00K
- Dr. Julia A. Haller, M.D.
- Independent Director
- 79.00K
- Dr. Gerd U. Auffarth, M.D.
- Independent Director
- 79.00K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
